Command Palette

Search for a command to run...

PREVEST

524.95+0.00%

Market Cap
₹630.10 Cr
Stock P/E
33.36
ROCE
25.24%
ROE
18.70%
Book Value
₹91.63

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Foreign Investors
Domestic Investors
Public

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Growth Outperformer

Prevest Denpro Ltd. stands out in the Medical Equipment sector with a solid ROCE and manageable debt levels, although it lacks revenue growth. Its peers show a mix of strengths and weaknesses in profitability and valuation, with Poly Medicure Ltd. emerging as a top growth performer, while Nureca Ltd. demonstrates financial stress.

Key Points
  • Prevest Denpro has a strong ROCE of 25.24% but lacks revenue growth.
  • Poly Medicure leads in revenue growth and profitability metrics.
  • Laxmi Dental, despite high ROE, shows signs of overvaluation with a PE of 100.52.
  • Nureca is financially risky with a negative PE and low ROE.
Top Performers
Poly Medicure Ltd.

Highest revenue growth at 21.37% YoY and solid profitability metrics.

Prevest Denpro Ltd.

Strong ROCE at 25.24% and low debt equity ratio.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.